# A systematic exploration of gut microbiota–driven blood metabolites in sepsis: an integrated bioinformatics and genetic association study

## TL;DR

This study explores how gut microbes influence sepsis through blood metabolites, identifying key metabolites that could be targeted for treatment.

## Contribution

The study provides novel evidence that gut microbiota affects sepsis via blood metabolites using integrated bioinformatics and genetic analysis.

## Key findings

- 15 blood metabolites mediate causal relationships between 12 gut microbiota taxa and sepsis.
- Gulonic acid and 4-hydroxyphenylacetic acid improve survival and reduce inflammation in septic mice.
- Network analysis identified five key metabolites and seven central molecular targets.

## Abstract

Alterations in the blood metabolome are closely associated with sepsis, while the gut microbiota (GM) plays a crucial role in modulating both sepsis progression and circulating metabolites. However, whether the effects of the GM on sepsis are mediated through blood metabolites remains unclear.

To determine whether the effects of the GM on sepsis are mediated through blood metabolites, we performed a two-sample Mendelian randomization (MR) analysis combined with a two-step MR framework to identify potential metabolic mediators. Comprehensive bioinformatics analyses were integrated to construct interaction networks using Cytoscape, and pharmacodynamic experiments were conducted in a murine sepsis model.

We identified 23 GM taxa and 169 blood metabolites significantly associated with sepsis. Two-step MR analysis revealed that 15 metabolites mediated the causal relationships between 12 GM taxa and sepsis, with mediation proportions ranging from 3.70% to 13.70%. A total of 131 potential molecular targets were predicted for these metabolites, and network analysis highlighted five key metabolites and seven central targets. Molecular docking demonstrated strong binding affinities between these metabolites and their targets. Notably, gulonic acid (GA) and 4-hydroxyphenylacetic acid (4-HPA), driven by Lentisphaerae, Lentisphaeria, and Victivallales, significantly improved survival and attenuated organ injury and inflammation in septic mice.

Collectively, this study provides evidence supporting a causal role of the GM in sepsis, which mediated in part by blood metabolites. These findings highlight the therapeutic potential of targeting both the GM and GM-driven metabolites as novel interventions for sepsis.

Infographic outlining a four-step research workflow: genetic associations between gut microbiome, blood metabolites, and sepsis; network pharmacology and interaction analysis; molecular docking visualizations and affinity heatmap analysis; and pharmacodynamics in septic mice, featuring survival curves, histology, biochemistry, inflammation assays, and PCR machine illustrations.